
(Reuters) -Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.
The Cambridge-based company plans to invest more than $140 million to add the final manufacturing step to its existing facility in Massachusetts.
The move will support both commercial and clinical supply as the company seeks to reduce reliance on contract manufacturers.
Construction has begun at the Moderna Technology Center in Norwood, with the company targeting completion by the first half of 2027. The expansion is expected to create hundreds of skilled biomanufacturing jobs.
"By onshoring drug product manufacturing to our campus in Norwood, Massachusetts, we have completed the full manufacturing loop under one roof in the U.S.," Chief Executive Stéphane Bancel said in a statement.
Moderna has historically relied on outside partners for the final drug product stage, known as fill-finish manufacturing. The new capabilities will allow the company to control the entire production process domestically.
The company gained global recognition during the COVID-19 pandemic when it developed Spikevax, one of the first coronavirus vaccines, through a partnership with the U.S. government's Operation Warp Speed program. Its mRNA technology platform is now being used to develop treatments for infectious diseases, cancer, rare diseases and autoimmune disorders.
Other drugmakers, including Pfizer and Eli Lilly, have also expanded U.S. manufacturing in recent years as the industry moves to reduce reliance on overseas production.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Maju Samuel)
latest_posts
- 1
Smooth countdown continues for Artemis II moon mission - 2
4 injured in shooting at North Carolina tree lighting ceremony - 3
NATO needs Ukraine's 'adaptation DNA' and an 'HOV lane' for new war tech, top commander says - 4
'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed - 5
Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens
The Most Notable Design Brands of the 21st Hundred years
Dad issues urgent plea to find stem cell donor for his son
Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
Smoking rate among US adults drops to record low as vape use rises, CDC report finds
Hezbollah rockets hit 165 UNIFIL positions in Lebanon while targeting Israel, IDF reveals
What to know about voluntary chocolate recall
Two more UN peacekeepers killed in southern Lebanon: UNIFIL
Pick Your Top Method for starting the Morning
Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says













